1,318 Shares in Cardinal Health, Inc. $CAH Acquired by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 1,318 shares of the company’s stock, valued at approximately $221,000.

Several other hedge funds have also made changes to their positions in the company. Atlantic Edge Private Wealth Management LLC grew its position in shares of Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares in the last quarter. Greykasell Wealth Strategies Inc. purchased a new stake in Cardinal Health in the first quarter worth about $26,000. NewSquare Capital LLC grew its holdings in Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after acquiring an additional 107 shares in the last quarter. Harbor Asset Planning Inc. purchased a new position in Cardinal Health during the 2nd quarter valued at about $49,000. Finally, Hantz Financial Services Inc. raised its holdings in shares of Cardinal Health by 44.8% in the 2nd quarter. Hantz Financial Services Inc. now owns 307 shares of the company’s stock valued at $52,000 after purchasing an additional 95 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $209.27 on Friday. The business’s 50-day moving average is $171.23 and its 200 day moving average is $161.11. Cardinal Health, Inc. has a 1 year low of $114.60 and a 1 year high of $210.32. The firm has a market capitalization of $49.72 billion, a P/E ratio of 32.45, a P/E/G ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter last year, the company earned $1.88 earnings per share. The company’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s payout ratio is currently 30.77%.

Wall Street Analyst Weigh In

CAH has been the topic of a number of recent research reports. Evercore ISI increased their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Argus increased their target price on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Jefferies Financial Group set a $220.00 price target on Cardinal Health and gave the company a “buy” rating in a report on Monday, November 3rd. Leerink Partners upped their price objective on Cardinal Health from $211.00 to $230.00 and gave the stock an “outperform” rating in a research note on Monday, November 17th. Finally, Wells Fargo & Company lifted their target price on Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $206.57.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.